Notably, these IFNβ‐expressing macrophages nearly doubled the median survival time in ovarian cancer‐bearing mice [396], suggesting that genetically enhanced macrophages could serve as a viable treatment option for solid tumors such as gastric cancer and ovarian cancer. The gene discussed is IFNB1; the disease is gastric cancer.